May 11, 2017 11:31 am UTC| Business
HOUSTON, May 11, 2017 -- Houston Wire Cable Company (Nasdaq:HWCC) today announced that James L. Pokluda, President CEO, is presenting at the East Coast IDEAS Investor Conference on Thursday, May 18th at 11:20 a.m....
Kforce to Present at the R.W. Baird 2017 Global Consumer, Technology & Services Conference
May 11, 2017 11:31 am UTC| Business
TAMPA, Fla., May 11, 2017 -- Kforce Inc. (NASDAQ:KFRC), today announced that David Kelly, CFO and Michael Blackman, CCDO of Kforce Inc. will present at the R.W. Baird 2017 Global Consumer, Technology Services...
Kforce to Present at the R.W. Baird 2017 Global Consumer, Technology & Services Conference
May 11, 2017 11:31 am UTC| Business
TAMPA, Fla., May 11, 2017 -- Kforce Inc. (NASDAQ:KFRC), today announced that David Kelly, CFO and Michael Blackman, CCDO of Kforce Inc. will present at the R.W. Baird 2017 Global Consumer, Technology Services...
Superconductor Technologies Reports 2017 First Quarter Results
May 11, 2017 11:05 am UTC| Business
AUSTIN, Texas, May 11, 2017 -- Superconductor Technologies Inc. (STI) (Nasdaq:SCON) reported financial results for the quarter ended April 1, 2017. Jeff Quiram, STI’s president and CEO, stated, “During the first...
iPass to Present at the 18th Annual B. Riley Co. Investment Conference
May 11, 2017 11:05 am UTC| Business
REDWOOD SHORES, Calif., May 11, 2017 -- iPass, Inc. (NASDAQ:IPAS), a leading provider of global mobile connectivity, announced Chief Executive Officer Gary Griffiths is scheduled to present at 8:00 am PT at the 18th...
Corium Reports Positive Preliminary Results in Alzheimer’s Clinical Study
May 11, 2017 11:02 am UTC| Business
MENLO PARK, Calif., May 11, 2017 -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products,...
May 11, 2017 11:02 am UTC| Business
Geneva, Switzerland and Boston, MA - May 11, 2017 - ObsEva SA (Nasdaq: OBSV), a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise...